Emergency Medicine Doctors in Great Falls, MT Accepting Medicare

27 Emergency Medicine doctors found. Showing 21 - 27

Philip E Donahue, FNP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-622-5955

Kevin Mccafferty, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-455-5200

Dr. Gerald Irvin Geiszler, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-761-6383

Dr. Cari Elaine Matthews, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-731-8888    Fax: 406-731-8876

Joie Abner, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-731-8888    Fax: 406-731-8318

Dr. Andrew Steven Taecker, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-455-5000

Nicholas Ray Burnham, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-455-5200

News Archive

Protein transporter in the gut could speed drug 'take up'

For poorly absorbed medications, drug makers should consider using natural homing devices to drive the drugs through the hazards of gastrointestinal acidity and enzymes to reach the bloodstream quicker, James Polli, PhD, said today at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS) in Atlanta.

Schools need to be more aware of head injuries

New research from the University of Warwick examining return to school and classroom performance following head injury reveals that teachers are often unaware of the injury and that children only very rarely receive specialist help, despite having attention and memory problems.

Atara Biotherapeutics secures $38.5M in initial closings under Series B financing

Atara Biotherapeutics, Inc., a drug development company with a focus on innovative therapies for patients with debilitating diseases, announced today that it has secured $38.5 million in initial closings under its Series B financing. In this round, investors Amgen Ventures, Celgene Corporation, and EcoR1 Capital, joined existing investors Alexandria Venture Investments, DAG Ventures, Domain Associates, and Kleiner Perkins Caufield & Byers.

Rockefeller University researchers identify new mechanism involved in early stem cell development

Stem cells work throughout our lives as a sort of handyman, repairing damaged tissues and renewing some normal ones, like the skin we shed. Scientists have come to understand much about how stem cells function when we are adults, but less is known about where these stem cells come from to begin with, as an embryo is developing.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)